000			01395nam a22002537a 4500
001			20241004094921.0
003			20241004094921.0
005			20241004095418.0
008			241004b |||||||| |||| 00| 0 eng d
020			_a978-3-319-03058-6
020			_a 978-3-319-03059-3
040			_cddc
041			_aEnglish
082			_a616.994 CAP
100			_qFederico Cappuzzo
245			_aGuide to Targeted Therapies _bEGFR Mutations in NSCLC.
260			_a London | _bSpringer International Publishing Switzerland | _c 2014
300			_a75 Pages
300			_aIncludes References
520			_a Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide.
600			_xMedical / General, Medical / Oncology / General, Medical / Pharmacology, Medical / Pulmonary & Thoracic Medicine, Medical sciences, Oncology, Respiratory organs—Diseases, Therapeutics, Epidermal growth factor, Lungs -- Cancer -- Treatment, Medicine, Medicine and Public Health, Pneumology.
856			_uDOI 10.1007/978-3-319-03059-3
942			_2ddc _cEB _n0
999			_c29045 _d29045